New pages
Jump to navigation
Jump to search
- 15:30, 18 July 2024 Efanesoctocog alfa (Altuviiio) (hist | edit) [1,825 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== ==Preliminary data== #'''XTEND-1:''' von Drygalski A, Chowdary P, Kulkarni R, Susen S, Konkle BA, Oldenburg J, Matino D, Klamroth R, Weyand AC, Jimene...")
- 12:01, 5 July 2024 CM-313 (hist | edit) [790 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== Anti-CD38 monoclonal antibody ==Preliminary data== ===Immune thrombocytopenia=== #'''2022-CM313-ITP:''' Chen Y, Xu Y, Li H, Sun T, Cao X, Wang Y,...")
- 12:53, 22 June 2024 Behenoyl cytarabine (BHAC) (hist | edit) [409 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== Lipid-conjugated derivative of cytarabine ==Diseases for which it was used== *Acute myeloid leukemia ==Also k...")
- 23:42, 21 June 2024 Bevacizumab-tnjn (Avzivi) (hist | edit) [4,072 bytes] Jwarner (talk | contribs) (Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Bevacizumab (Avastin) page, except for the details of FDA indication and the refe...")
- 13:42, 14 June 2024 HemOnc.org Internship (hist | edit) [6,351 bytes] Warner-admin (talk | contribs) (Created page with "=2024-2025 Internship= =Past interns= To be completed Category:General reference pages")
- 19:08, 30 May 2024 Congenital thrombotic thrombocytopenic purpura (hist | edit) [2,677 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:29, 30 May 2024 Rusfertide (PTG-300) (hist | edit) [743 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== Hepcidin mimetic ==Preliminary data== ===Polycythemia vera=== #'''REVIVE:''' Kremyanskaya M, Kuykendall AT, Pemmaraju N, Ritchie EK, Gotlib J, Ger...")
- 14:27, 28 May 2024 HemOnc.org LLC (hist | edit) [1,484 bytes] Warner-admin (talk | contribs) (Created page with "HemOnc.org LLC is a Limited Liability Company, incorporated in Massachusetts (2017). The Officers are uncompensated; shares have no monetary value. {{TOC limit|limit=1}} =Lea...")
- 02:23, 25 May 2024 Liposarcoma - null regimens (hist | edit) [2,806 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:42, 24 May 2024 Trastuzumab-strf (Hercessi) (hist | edit) [2,140 bytes] Jwarner (talk | contribs) (Created page with "'''Note: this is a biosimilar. The information below is reproduced from the Trastuzumab (Herceptin) page, except for the details of FDA indication.''' ==General informatio...")
- 01:21, 24 May 2024 Cholangiocarcinoma - historical (hist | edit) [4,886 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 16:12, 17 May 2024 Ovarian irradiation (hist | edit) [41 bytes] Jwarner (talk | contribs) (Created page with "Category:Endocrine ablation radiation")
- 16:09, 17 May 2024 Bilateral oophorectomy (hist | edit) [39 bytes] Jwarner (talk | contribs) (Created page with "Category:Endocrine ablation surgery")
- 16:08, 17 May 2024 Bilateral adrenalectomy (hist | edit) [39 bytes] Jwarner (talk | contribs) (Created page with "Category:Endocrine ablation surgery")
- 15:33, 17 May 2024 Bilateral orchiectomy (hist | edit) [168 bytes] Jwarner (talk | contribs) (Created page with "A surgical procedure primarily intended to remove endogenous testosterone production. Category:Endocrine ablation surgery Category:Androgen-deprivation therapy")
- 00:44, 16 May 2024 Venous thromboembolism - null regimens (hist | edit) [7,939 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:40, 16 May 2024 Follicular lymphoma - null regimens (hist | edit) [26,647 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:22, 16 May 2024 Chronic lymphocytic leukemia - null regimens (hist | edit) [16,844 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:06, 16 May 2024 B-cell acute lymphoblastic leukemia, pediatric - null regimens (hist | edit) [2,496 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:55, 15 May 2024 Thrombocytopenia in liver disease - null regimens (hist | edit) [4,286 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:43, 15 May 2024 Paroxysmal nocturnal hemoglobinuria - null regimens (hist | edit) [2,791 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:30, 15 May 2024 Essential thrombocythemia - null regimens (hist | edit) [1,961 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:26, 15 May 2024 Periampullary adenocarcinoma - null regimens (hist | edit) [3,258 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:06, 15 May 2024 Immune thrombocytopenia - null regimens (hist | edit) [10,727 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 22:58, 15 May 2024 Pancreatic cancer, BRCA-mutated - null regimens (hist | edit) [3,608 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:17, 15 May 2024 Castleman disease - null regimens (hist | edit) [2,976 bytes] Jwarner (talk | contribs) (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:51, 14 May 2024 ADAMTS13, recombinant (Adzynma) (hist | edit) [858 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== Replacement therapy ==Diseases for which it is established== *Congenital thrombotic thrombocytopenic purpura ==Diseases for which it is used== *[...")
- 23:34, 14 May 2024 Exagamglogene autotemcel (Casgevy) (hist | edit) [790 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== Gene therapy ==Diseases for which it is established== *Beta thalassemia *Sickle cell disease (SCD) ==History of changes in...")
- 21:54, 28 April 2024 Tovorafenib (Ojemda) (hist | edit) [1,193 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovorafenib NCI Drug Dictionary]: An orally available inhibitor of wild-type...")